Fact Source: Financial Supervisory Service DART
💡 Executive Summary
Hana Micron set December 31, 2024, as the record date to determine shareholders entitled to exercise voting rights at the 24th Annual General Meeting of Shareholders, and corrected the board resolution date to December 16, 2024, due to a clerical error.
📊 Key Disclosure Content & Financial Figures Summary
- Company Name: Hana Micron Inc.
- Original Filing Subject to Correction: Setting of Closure Period of Shareholders’ Register or Record Date [Original Filing Date: December 16, 2024]
- Reason for Correction: Simple clerical error
- Corrected Item:
- Board Resolution Date: (Before) December 13, 2024 -> (After) December 16, 2024
- Record Date Details:
- Record Date: December 31, 2024
- Closure Period for Entry of Change: Not stated (pursuant to the Act on Electronic Registration of Stocks, Bonds, Etc.)
- Purpose: Determination of eligible shareholders for holding the 24th Annual General Meeting of Shareholders
- Board Resolution Date: December 16, 2024
- Other References for Investment Decision:
- Pursuant to Article 17 (Closure of Shareholders’ Register and Record Date) of the Articles of Incorporation.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Correction Details and Annual General Meeting Notices
This filing discloses the corrected board resolution date (December 16, 2024) following a clerical error, along with establishing the record date (December 31, 2024) for voting rights at the 24th Annual General Meeting of Shareholders. Checking the record date set for exercising voting rights is important for tracking upcoming shareholder meeting schedules and proposals. Further details can be verified through future official disclosures, such as the Board Resolution on AGM Convening, AGM Notices, and Annual Reports.
📢 Disclaimer & Source Information
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Disclaimer: This content is provided solely for information purposes and linguistic reference. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial risks rest solely with the investor.
Contact: For compliance inquiries or copyright-related issues, please contact ksb220805@gmail.com.
